356 related articles for article (PubMed ID: 9681092)
1. Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction.
Michalets EL; Smith LK; Van Tassel ED
Ann Pharmacother; 1998; 32(7-8):761-5. PubMed ID: 9681092
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
Glassman AH; Bigger JT
Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
[TBL] [Abstract][Full Text] [Related]
3. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic antidepressants, QT interval prolongation, and torsade de pointes.
Vieweg WV; Wood MA
Psychosomatics; 2004; 45(5):371-7. PubMed ID: 15345781
[TBL] [Abstract][Full Text] [Related]
5. Haloperidol-induced torsade de pointes.
O'Brien JM; Rockwood RP; Suh KI
Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216
[TBL] [Abstract][Full Text] [Related]
6. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Lawrence KR; Nasraway SA
Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
[TBL] [Abstract][Full Text] [Related]
7. Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
Nuttall GA; Eckerman KM; Jacob KA; Pawlaski EM; Wigersma SK; Marienau ME; Oliver WC; Narr BJ; Ackerman MJ
Anesthesiology; 2007 Oct; 107(4):531-6. PubMed ID: 17893447
[TBL] [Abstract][Full Text] [Related]
8. Torsade de Pointes after administration of droperidol for nausea and vomiting.
Choo EK; Weber FS; Schmidt TA
Prehosp Emerg Care; 2009; 13(2):261-5. PubMed ID: 19291568
[TBL] [Abstract][Full Text] [Related]
9. Long QTc interval and torsade de pointes caused by fluconazole.
Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
Haddad PM; Anderson IM
Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
[TBL] [Abstract][Full Text] [Related]
11. Droperidol in the emergency department: is it safe?
Richards JR; Schneir AB
J Emerg Med; 2003 May; 24(4):441-7. PubMed ID: 12745049
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmias related to antipsychotics and antidepressants: an analysis of the summaries of product characteristics of original products approved in Germany.
Elsayed M; Abdel-Kahaar E; Gahr M; Connemann BJ; Denkinger M; Schönfeldt-Lecuona C
Eur J Clin Pharmacol; 2021 May; 77(5):767-775. PubMed ID: 33230596
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors.
Letsas KP; Efremidis M; Kounas SP; Pappas LK; Gavrielatos G; Alexanian IP; Dimopoulos NP; Filippatos GS; Sideris A; Kardaras F
Clin Res Cardiol; 2009 Apr; 98(4):208-12. PubMed ID: 19031039
[TBL] [Abstract][Full Text] [Related]
14. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
15. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
Vieweg WV; Schneider RK; Wood MA
Acta Psychiatr Scand; 2005 Oct; 112(4):318-22; author reply 322. PubMed ID: 16156840
[TBL] [Abstract][Full Text] [Related]
16. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.
Vieweg WV; Wood MA; Fernandez A; Beatty-Brooks M; Hasnain M; Pandurangi AK
Drugs Aging; 2009; 26(12):997-1012. PubMed ID: 19929028
[TBL] [Abstract][Full Text] [Related]
17. Safety of droperidol in behavioural emergencies.
Shale JH; Shale CM; Mastin WD
Expert Opin Drug Saf; 2004 Jul; 3(4):369-78. PubMed ID: 15268653
[TBL] [Abstract][Full Text] [Related]
18. Droperidol, QT prolongation, and sudden death: what is the evidence?
Kao LW; Kirk MA; Evers SJ; Rosenfeld SH
Ann Emerg Med; 2003 Apr; 41(4):546-58. PubMed ID: 12658255
[TBL] [Abstract][Full Text] [Related]
19. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
De Ponti F; Poluzzi E; Cavalli A; Recanatini M; Montanaro N
Drug Saf; 2002; 25(4):263-86. PubMed ID: 11994029
[TBL] [Abstract][Full Text] [Related]
20. Sulpiride induced torsade de pointes.
Huang BH; Hsia CP; Chen CY
Int J Cardiol; 2007 Jun; 118(3):e100-2. PubMed ID: 17408770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
